Home PhagoMed

PhagoMed

In operation
Equity Financing
Phage Therapy Developer

Basic Information

PhagoMed Biopharma Develops Phage Therapies as Antibiotic Alternatives to Address the Urgent Medical Need for New Antibiotics. The Platform Focuses on Developing Human Therapeutic Applications of Phages and Phage-Derived Proteins Related to Urinary Tract Infections and Bacterial Vaginosis, Enabling Patients to Access Antibiotics.
PhagoMed Biopharma GmbH
Austria
unclear
November 23, 2017
contact@phagomed.com